Literature DB >> 17657703

[MRI in giant cell (temporal) arteritis].

T A Bley1, M Uhl, M Markl, A Frydrychowicz, M Langer.   

Abstract

Giant cell (temporal) arteritis is a diagnostic challenge. Blindness is a dreaded complication, especially if high-dose steroid treatment is delayed. With an optimized MR protocol, noninvasive diagnosis of giant cell arteritis is facilitated. Submillimeter in-plane resolution makes it possible to distinguish healthy segments from inflamed segments. The lumen and arterial wall can be depicted in high detail. Post-contrast high-resolution MRI visualizes the superficial cranial arteries bilaterally and simultaneously, allowing assessment of the cranial involvement pattern. In combination with MR angiography of the aortic arch and supra-aortic arteries, the extracranial involvement pattern can be demonstrated in a single comprehensive MR examination assessing the cranial, cervical and thoracic vasculature. Good diagnostic image quality can be achieved at 1.5 Tesla and at 3 Tesla. However, due to higher signal-to-noise ratios, image quality seems to be superior at 3 Tesla. Over the course of successful long-term treatment, MR signs of mural inflammation decrease significantly and eventually vanish entirely. In contrast to color-coded Duplex sonography, which is a comparatively cost-efficient imaging modality, acquisition of high-resolution MRI is almost independent of the investigator's expertise. Compared to positron emission tomography with 18F-fluoro-2-deoxy-D-glucose, which is a very sensitive whole-body screening tool for detecting extracranial involvement of large vessel vasculitis, MRI allows visualization and assessment of both the superficial cranial arteries in high detail and the extracranial large artery involvement in the same investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657703     DOI: 10.1055/s-2007-963123

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

Review 1.  [Imaging techniques in the evaluation of primary large vessel vasculitides: part 1: angiography, interventional therapy, and magnetic resonance imaging].

Authors:  M Both; B Nölle; C von Forstner; F Moosig; W L Gross; M Heller
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

2.  Magnetic resonance angiography in extracranial giant cell arteritis.

Authors:  Marcel Koenigkam-Santos; Puneet Sharma; Bobby Kalb; John N Oshinski; Cornelia M Weyand; Jörg J Goronzy; Diego R Martin
Journal:  J Clin Rheumatol       Date:  2011-09       Impact factor: 3.517

Review 3.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

4.  3-T MRI detects inflammatory stenosis of the vertebral artery in giant cell arteritis.

Authors:  J Geiger; M Uhl; H H Peter; M Langer; T A Bley
Journal:  Clin Rheumatol       Date:  2008-01-03       Impact factor: 2.980

5.  MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis.

Authors:  Simon Veldhoen; Thorsten Klink; Julia Geiger; Peter Vaith; Cornelia Glaser; Thomas Ness; Dirk Duwendag; Marcus Both; Thorsten A Bley
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

6.  [Large-vessel vasculitis. Imaging and interventional therapy].

Authors:  M Both; F Moosig; W L Gross; M Heller
Journal:  Radiologe       Date:  2009-10       Impact factor: 0.635

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.